CPH Pharma ApS: Financial statements 2024
CVR: 37110248
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,353,608 and a net result of DKK 1,257,143 compared with DKK 1,034,324 the year before. That is an increase of 11.2% compared with the year before. Equity in the 2024 report amounted to DKK 3,220,451. The solvency ratio was 77.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,353,608
- Profit/Loss
- DKK 1,257,143
- Equity
- DKK 3,220,451
- Total Assets
- DKK 4,158,139
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.4 mio. | 1.3 mio. | 3.2 mio. | 3 |
| 2023 | - | 3 mio. | 1 mio. | 2 mio. | 3 |
| 2022 | - | 1.7 mio. | 587 t. | 1.3 mio. | 2 |
| 2021 | - | 1.6 mio. | 895 t. | 1 mio. | 1 |
| 2020 | - | 1 mio. | 480 t. | 447 t. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CPH Pharma ApS has published its annual report for 2023. Gross profit came to DKK 3,016,998, and the net result was DKK 1,034,324.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.